Help us celebrate 5 amazing years of being the first 5K Run/Walk dedicated to raising awareness of triple negative breast cancer (TNBC).
Sunday, September 21, 2014
Lake Merritt Park, Oakland, CA
Saturday, October 4, 2014
Alondra Park, Lawndale, CA
A Big THANK YOU to Total Beauty Shops for donating a percentage of proceeds from the Pink Embrace Collection to raise awareness for TNBC. To learn more and enter the Pink Embrace Sweepstakes for your chance to win, click here.
Our Fourth Annual Stepping Towards the Cure® 5K Run/Walk is back! Please mark your calendars and get ready to join us as we step out to promote awareness of triple negative breast cancer and support our survivors.
In recognition of the first Inaugural Triple Negative Awareness Day, please join us for a special FREE screening of In the Family, a documentary film about predicting breast and ovarian cancer, the consequences of knowing, and the women who live with the risk. Beginning with her own story of testing positive for the familial breast cancer mutation (BRCA), filmmaker Joanna Rudnick chronicles the lives of several women undergoing the process of genetic testing. The screening will be followed by a Q & A discussion with the filmmaker, Joanna Rudnick. Refreshments will be served. Please RSVP before March 1, 2013.
Please join Triple Step Toward the Cure in supporting the First Annual Triple Negative Breast Cancer Day on 3-3-13! Created by the Triple Negative Breast Cancer Foundation, Triple Negative Breast Cancer Day was designed to increase awareness of triple negative breast cancer and raise funds to support research to find targeted therapies for the disease.
Team Triple Step rallied the troops for our Third Annual “Stepping Towards the Cure®” 5K, held in both Oakland and Long Beach. Big THANKS to all of our sponsors, celebrity spokespersons, and Participants who came out to Run, Walk, Volunteered, & Donate to help make both events a success!
Team Triple Step rallied the troops for our Third Annual "Stepping Towards the Cure®" 5K, held in both Oakland and Long Beach. Big THANKS to all of our sponsors, celebrity spokespersons, and Participants who came out to Run, Walk, Volunteered, & Donate to help make both events a success!
Researchers look at triple negative breast cancer.
New research is being funded into a particularly deadly form of breast cancer that takes a heavy toll on younger women.More Details >
- Stephanie Pappas (Stanford Medicine)
Summary: This is a Phase I dose escalation study of cisplatin and concurrent radiation in patients with ER negative, PR negative and HER2 negative breast cancer who have undergone breast-conserving surgery.
Summary: it is estimated that 20% of women diagnosed with breast cancer in the state of California will have harmone receptor-negative (HRN) invasive breast cancer,...
COLUMBUS, Ohio - Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) are recruiting patients for two clinical trials for women with "triple negative" breast cancer, an aggressive form of breast cancer that resists treatment.
August 4, 2013
I have always been a hard-working person, trying to never let anyone down. I love being a mom to my teenage daughter and my three dogs. I have an amazing, supportive husband and we just celebrated our Anniversary of 20 years. I do everything in life to be that good person! I am dedicated to work and my family, paying my bills, going for regular check-ups, and being there for everyone else in their time of need. Basically, I'm just always doing what is RIGHT and GOOD! I now struggle with recently being diagnosed and going through the fight with breast cancer. Who knew that I would eventually find myself with triple negative breast cancer...what did I do wrong? Why me?
September 27, 2013
My breast cancer story has a little bit of a different twist than most. I was one who did not discover a lump on my breast. My discovery was via a lump under my armpit which made practicing Bikram Yoga very painful.
Men and women living with advanced breast cancer due to a BRCA1/2 gene mutation may qualify for a new clinical research study known as the BROCADE Study. This study will determine the safety and effectiveness of veliparib, an experimental anti-cancer drug, in combination with chemotherapy. You may qualify for the study if you are 18 years of age or older, have metastatic or locally recurrent breast cancer and a BRCA1 or 2 mutation, and have not received more than two prior cancer treatments for advanced breast cancer.
People who enroll in the study will be randomized (like flipping a coin) in a 1:1:1 ratio to one of three study treatment groups: veliparib with temozolomide, veliparib with carboplatin and paclitaxel, or placebo with carboplatin and paclitaxel. Temozolomide, carboplatin, and paclitaxel are chemotherapy drugs approved for use in routine cancer care. A placebo is a look-alike pill with no active ingredients. Participants may receive compensation or reimbursement for travel to and from the study center.
If you are interested in learning more about this study, talk to your oncologist, visit the BROCADE Study website at www.BROCADEStudy.com , or call + 1 855 5ONCOLOGY (+ 1 855 566 2656) to speak with an experienced study nurse to determine if the BROCADE Study is right for you.